Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 17, 2003
A reappraisal of local anesthesia for prostate brachytherapyAmy Mueller, Kent Wallner, Jacques Corriveau, et al.
Cancer Journal (Sudbury, Mass.)|March 16, 2002
I-125 versus Pd-103 for low-risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trialKent Wallner, Gregor Merrick, Lawrence True, et al.
Practical Radiation Oncology|March 5, 2023
Matching Protocol and Practice: The Challenge of Meeting Lung and Kidney Total Body Irradiation Constraints for SclerodermaBing-Hao Chiang, Kent Wallner, Ralph Ermoian, et al.
Clinical Journal of Oncology Nursing|October 21, 2005
Factors affecting patient selection for prostate brachytherapy: what nurses should knowDebra Zeroski, Laurie Abel, Wayne M Butler, et al.
Urology|February 5, 2008
Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapyL Christine Fang, Michael Dattoli, Al Taira, et al.
Pain Practice : the Official Journal of World Institute of Pain|July 26, 2014
Patient Satisfaction with Fentanyl Sublingual Spray in Opioid-Tolerant Patients with Breakthrough Cancer PainRichard Rauck, Neha Parikh, Larry Dillaha, et al.
Brachytherapy|April 6, 2004
Late urinary function after prostate brachytherapyDaniel Landis, Kent Wallner, Jacob Locke, et al.
American Journal of Ophthalmology Case Reports|March 14, 2025
Simultaneous conjunctival melanomas in one eye treated with both adjuvant brachytherapy and proton beam radiotherapyLaura D Selby, Kent Wallner, Evan Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapySubir Nag, Rodney J Ellis, Gregory S Merrick, et al.
Brachytherapy|January 6, 2026
Randomized trial of dose de-escalation in low-risk prostate cancer patients implanted with Pd-103Martin King, Grgur Mirić, Mutlay Sayan, et al.
Pageof 10